Herpes simplex type 2 neutralization antibodies in patients with cancers of urinary bladder, prostate, and cervix
✍ Scribed by Güven Lüleci; Meral Sakizli; Altan Günalp; Ilhan Erkan; Dogan Remzi
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 250 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Recent epidemiological studies suggest that the risk for urological malignancies may be related to the exposure to infectious agents. Human Papillomaviruses type 16 and 18 (HPV 16, HPV 18), Epstein-Barr virus (EBV), cytomegalovirus (CMV) and herpes simplex virus type 2 (HSV-2) have been suggested pr
## Abstract The incidence of anti‐AG‐4 complement‐fixing antibodies in Australian cervical carcinoma (CaCx), herpes simplex virus (HSV) type 1 and 2, and control patients, was investigated using local HSV strains. The local HSV strains (both HSV‐1Ml and HSV‐2Ml) were found, by neutralization experi
## Abstract Sera collected from patients with cervical epithelial atypia, carcinoma in situ and invasive carcinoma, as well as from control subjects, were examined for the presence of HSV‐1 and HSV‐2 antibodies. All these subjects came from one district of Prague. In agreement with results reported
## Abstract A quantitative polymerase chain reaction (PCR) assay was evaluated retrospectively on 92 cerebrospinal fluid (CSF) samples from 29 patients with herpes simplex virus (HSV) encephalitis with the aim to study if the concentration of HSV genomes can be used as a prognostic marker and for m